{"slug":"biomarkers","tag":"biomarkers","variants":["biomarkers"],"description":"No description yet","count":4,"kinds":{"person":4},"related":[{"slug":"ai","tag":"ai","shared":1},{"slug":"breast","tag":"breast","shared":1},{"slug":"germany","tag":"germany","shared":1},{"slug":"glioma","tag":"glioma","shared":1},{"slug":"mgmt","tag":"mgmt","shared":1},{"slug":"pathology","tag":"pathology","shared":1},{"slug":"platform-trial","tag":"platform-trial","shared":1},{"slug":"tnbc","tag":"tnbc","shared":1},{"slug":"translational","tag":"translational","shared":1}],"records":[{"id":"mitch-dowsett","kind":"person","name":"Mitch Dowsett","route":"/people/mitch-dowsett/","tldr":"The translational scientist behind the aromatase inhibitor era and the Ki67 response test used in POETIC."},{"id":"lajos-pusztai","kind":"person","name":"Lajos Pusztai","route":"/people/lajos-pusztai/","tldr":"Translational breast oncologist who co-leads the I-SPY2 platform trial and helped show immunotherapy works in early TNBC."},{"id":"monika-hegi","kind":"person","name":"Monika E. Hegi","route":"/people/monika-hegi/","tldr":"Showed that MGMT promoter methylation predicts benefit from temozolomide, the biomarker every glioblastoma patient is now tested for."},{"id":"jakob-nikolas-kather","kind":"person","name":"Jakob Nikolas Kather","route":"/people/jakob-nikolas-kather/","tldr":"Showed that deep learning can read genetic features like microsatellite instability directly from routine pathology slides."}]}